EASOobesity

EASOobesity EASO represents 36 European nations dedicated to understanding and addressing obesity.

Dr Andreea Ciudin describes the EASO Pharmacological Framework for obesity management - emphasising that medication is n...
24/02/2026

Dr Andreea Ciudin describes the EASO Pharmacological Framework for obesity management - emphasising that medication is not the first component in obesity mgmt. And patient first approaches are crucial. Thank you for joining!

TRANSFORM: Training Experts for Tomorrow ➡️ 15–17 March 2026 The Netherlands 🇳🇱🌟 TRANSFORM is an educational training pr...
22/02/2026

TRANSFORM: Training Experts for Tomorrow ➡️ 15–17 March 2026 The Netherlands 🇳🇱

🌟 TRANSFORM is an educational training programme designed for early/mid-career medical specialists with a focus on obesity.

The programme has been developed by Professor Erica van den Akker and Professor Luca Busetto, with the goal of providing an interactive environment for attendees to collaborate with scientific leaders and their peers in the field, whilst gaining the latest knowledge and skills relevant to their day-to-day practice.

To ensure all delegates benefit from the programme, participants will be required to develop a short case study based on one key topic from the following:
✔️Clinical evaluation
✔️Diagnostics
✔️Treatment

Learn more about the eligibility criteria and how to apply: https://easo.org/transform-training-obesity-experts-for-tomorrow/

Day 2 at the   plenary in Bern 🇨🇭 the team are discussing how to clearly and responsibly communicate about   (PRS) in th...
20/02/2026

Day 2 at the plenary in Bern 🇨🇭 the team are discussing how to clearly and responsibly communicate about (PRS) in the context of health 🧬

Interesting changes in processed foods coming:  shorter ingredient lists and smaller pack sizes in 2026 as more people t...
20/02/2026

Interesting changes in processed foods coming: shorter ingredient lists and smaller pack sizes in 2026 as more people take appetite-suppressing GLP-1 medications.

Companies that previously took a wait-and-see attitude now see GLP-1s as here to stay HT

Global food and beverage companies from PepsiCo to Coca-Cola are focusing on shorter ingredient lists and smaller pack sizes in 2026 as more people take appetite-suppressing GLP-1 drugs for weight loss.

Meet the EASO COM Division of Pediatric Endocrinology and Diabetes at the Department of Paediatrics and Adolescent Medic...
20/02/2026

Meet the EASO COM Division of Pediatric Endocrinology and Diabetes at the Department of Paediatrics and Adolescent Medicine, University Medical Center Ulm, Germany, led by Prof Martin Wabitsch 🇩🇪

This COM is internationally recognised for
✔️Excellence in childhood and adolescent obesity research and care
✔️Advanced clinical practice with strong national and European collaborations.
✔️Patient care philosophy and approach

Learn more about this COM and
✔️Treatments and services offered
✔️How they engage with the wider community and health system
✔️Their challenges and goals for the next 3–5 years ✔️Recent achievements and research updates

Read more: https://easo.org/meet-the-easo-coms-division-of-pediatric-endocrinology-and-diabetes-university-medical-center-ulm-germany/

Address


Alerts

Be the first to know and let us send you an email when EASOobesity posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Contact The Practice

Send a message to EASOobesity:

  • Want your practice to be the top-listed Clinic?

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

COVID-19 AND OBESITY

The EASO medical and scientific community all across Europe is intensively engaged in addressing the global COVID-19 pandemic. Our clinicians are working in the front line of care daily for patients living with obesity within emergency care systems, in coordination with other clinical colleagues across 34 countries. Our scientists are hard at work developing tools and frameworks for contributing to psychological support for clinicians and patients, developing and implementing public health strategies, providing guidance and support for whole family assistance, and development and provision of advice for children and teens.

Our role in this crisis will be crucial in the dissemination of science-based information and providing common-sense, evidence-based updates, recommendations and guidance via our website and social media, that can reach millions of people. EASO is committed to sharing only the latest well evidenced information and guidance from credible sources.

People living with the chronic disease obesity are particularly vulnerable to the effects of the novel coronavirus, and appear to have a higher rate of serious complications from the virus. It is paramount that people with obesity avoid infection. We herein recommend that people with obesity shelter at home during this time, following their national guidance for vulnerable people living with chronic disease.

Infographics developed in conjunction with our scientific and patient communities focused on energy balance; mental health; family life with children and adolescents;and indoor exercise, all helpful during COVID-19, are available for download on the EASO website.